AdamsP, AltesA, BrissotP, ButzeckB, CabantchikI, CançadoR, DistanteS, EvansP, EvansR, GanzT, GirelliD, HultcrantzR, McLarenG, MarrisB, MilmanN, NemethE, NielsenP, PineauB, PipernoA, PortoG, PrinceD, RyanJ, SanchezM, SantosP, SwinkelsD, TeixeiraE, ToskaK, VancloosterA, WhiteD, et al.Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) hom*ozygous genotype.Hepatol Int.2018;12:83–6. [PMC free article: PMC5904234] [PubMed: 29589198]
AdamsPC, BartonJC. How I treat hemochromatosis.Blood.2010;116:317–25. [PubMed: 20308595]
AdamsPC, ReboussinDM, BartonJC, McLarenCE, EckfeldtJH, McLarenGD, DawkinsFW, ActonRT, HarrisEL, GordeukVR, Leiendecker-FosterC, SpeechleyM, SnivelyBM, HolupJL, ThomsonE, SholinskyP. Hemochromatosis and iron-overload screening in a racially diverse population.N Engl J Med.2005;352:1769–78. [PubMed: 15858186]
AdrisN, HazeldineS, BentleyP, TrinderD, ChuaACG, PowellLW, RammLE, RammGA, OlynykJK. Detection of HFE haemochromatosis in the clinic and community using standard erythrocyte tests.Blood Cells Mol Dis.2019;74:18-24. [PubMed: 30340937]
AllenKJ, GurrinLC, ConstantineCC, OsborneNJ, DelatyckiMB, NicollAJ, McLarenCE, BahloM, NisselleAE, VulpeCD, AndersonGJ, SoutheyMC, GilesGG, EnglishDR, HopperJL, OlynykJK, PowellLW, GertigDM. Iron-overload-related disease in HFE hereditary hemochromatosis.N Engl J Med.2008;358:221–30. [PubMed: 18199861]
BaconBR, AdamsPC, KowdleyKV, PowellLW, TavillAS, et al.Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.Hepatology.2011;54:328–43. [PMC free article: PMC3149125] [PubMed: 21452290]
Bardou-JacquetE, de TayracM, MosserJ, DeugnierY.GNPAT variant associated with severe iron overload in HFE hemochromatosis.Hepatology.2015a;62:1917–8. [PubMed: 25891252]
Bardou-JacquetE, LainéF, DeugnierY.Reply to: "Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials."J Hepatol.2015b;63:283–4. [PubMed: 25841362]
Bardou-JacquetE, MorcetJ, ManetG, LainéF, PerrinM, JouanolleAM, GuyaderD, MoirandR, VielJF, DeugnierY. Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis.J Hepatol.2015c;62:682–9. [PubMed: 25450707]
BartonJC, ActonRT, DawkinsFW, AdamsPC, LovatoL, Leiendecker-FosterC, McLarenCE, ReboussinDM, SpeechleyMR, GordeukVR, McLarenGD, SholinskyP, HarrisEL. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.Genet Test.2005;9:231-41. [PubMed: 16225403]
Barton JC, Barton JC, Acton RT. Iron overload phenotypes and HFE genotypes in white Hemochromatosis and Iron Overload Screening Study participants without HFE p.C282Y/p.C282Y. PLoS One. 2022;27;17:e0271973. [PMC free article: PMC9328571] [PubMed: 35895739]
BartonJC, BartonJC, ActonRT. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.BMC Gastroenterology.2023;23:137. [PMC free article: PMC10148383] [PubMed: 37118679]
BartonJC, BartonJC, AdamsPC. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y hom*ozygotes.Ann Hepatol.2019;18:354-359. [PubMed: 31056361]
BartonJC, BertoliLF, RothenbergBE. Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content.J Lab Clin Med2000;135:96-104. [PubMed: 10638700]
BartonJC, BottomleySS. Iron deficiency due to excessive therapeutic phlebotomy in hemochromatosis.Am J Hematol.2000;65:223–6. [PubMed: 11074539]
BartonJC, EdwardsCQ, ActonRT. HFE gene: structure, function, mutations, and associated iron abnormalities.Gene.2015;574:179–92. [PMC free article: PMC6660136] [PubMed: 26456104]
BartonJC, McLarenCE, ChenWP, RammGA, AndersonGJ, PowellLW, SubramaniamVN, AdamsPC, PhatakPD, GurrinLC, PhillipsJD, ParkerCJ, EmondMJ, McLarenGD. Cirrhosis in hemochromatosis: independent risk factors in 368 HFE p.C282Y hom*ozygotes.Ann Hepatol.2018;17:871–9. [PMC free article: PMC6368858] [PubMed: 30145563]
Barton JC, Parker CJ. Hemochromatosis. In: Means RT Jr, Roders GM, Glader B, Arber DA, Appelbaum FR, Disperenzieri A, Fehniger TA, Michaelis LC, Leonard JPl, eds. Wintrobe's Clinical Hematology. 15 ed. Philadelphia, PA: Wolters-Kluwer/Lippincott Williams and Wilkins; 2023:ch 27.
BeutlerE, FelittiVJ, KoziolJA, HoNJ, GelbartT. Penetrance of 845G-->A (C282Y) HFE hereditary haemochromatosis mutation in the USA.Lancet.2002;359:211–8. [PubMed: 11812557]
BomfordA, WilliamsR. Long term results of venesection therapy in idiopathic haemochromatosis.Q J Med1976;45:611–623. [PubMed: 188063]
CadeJE, MoretonJA, O'HaraB, GreenwoodDC, MoorJ, BurleyVJ, KukalizchK, BishopDT, WorwoodM. Diet and genetic factors associated with iron status in middle-aged women.Am J Clin Nutr.2005;82:813-820. [PubMed: 16210711]
CançadoR, MeloMR, de MoraesBastos, SantosPCJL, Guerra-ShinoharaEM, ChiattoneC, BallasSK. Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study. Eur J Haematol.2015;95:545-50. [PubMed: 25684349]
CaugheyAB, KristAH, WolffTA, BarryMJ, HendersonJT, OwensDK, DavidsonKW, SimonMA, MangioneCM. USPSTF approach to addressing sex and gender when making recommendations for clinical preventive services.JAMA. 2021;326:1953-61. [PubMed: 34694343]
DelatyckiMB, GurrinLC, OngSY, RammGA, AndersonGJ, OlynykJK, AllenKJ, NicollAJ, PowellLW. Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials.J Hepatol.2015;63:282–3. [PubMed: 25839407]
DeugnierY, JouanolleA-M, ChaperonJ, MoirandR, PithoisC, MeyerJ-F, PouchardM, LafraiseB, BrigandA, Caserio-SchoenemannC, MosserJ, AdamsP, Le GallJ-Y, DavidV. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people.Br J Haematol.2002;118:1170-8. [PubMed: 12199803]
DobrindtEM, KeshiE, NeulichedlJ, SchöningW, ÖllingerR, PratschkeJ, EurichD. Long-term outcome of orthotopic liver transplantation in patients With hemochromatosis: a summary of a 30-year transplant program.Transplant Direct.2020;6:e560. [PMC free article: PMC7531770] [PubMed: 33062844]
El-SeragHB, InadomiJM, KowdleyKV. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis.Ann Intern Med.2000;132:261–9. [PubMed: 10681280]
European Association for the Study of the Liver. EASL clinical practice guidelines for HFE hemochromatosis.J Hepatol.2010;53:3–22. [PubMed: 20471131]
European Association for the Study of the Liver. EASL clinical practice guidelines on haemochromatosis.J Hepatol.2022;77:479-502. [PubMed: 35662478]
FederJN, GnirkeA, ThomasW, TsuchihashiZ, RuddyDA, BasavaA, DormishianF, DomingoRJr, EllisMC, FullanA, HintonLM, JonesNL, KimmelBE, KronmalGS, LauerP, LeeVK, LoebDB, MapaFA, McClellandE, MeyerNC, MintierGA, MoellerN, MooreT, MorikangE, PrassCE, QuintanaL, StarnesSM, SchatzmanRC, BrunkeKJ, DraynaDT, RischNJ, BaconBR, WolffRK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.Nat Genet.1996;13:399–408. [PubMed: 8696333]
FeldmanAG, WhitingtonPF. Neonatal hemochromatosis.J Clin Exp Hepatol.2013;3:313–20. [PMC free article: PMC3940210] [PubMed: 25755519]
GirelliD, BustiF, BrissotP, CabantchikI, MuckenthalerMU, PortoG. Hemochromatosis classification: update and recommendations by the BIOIRON Society.Blood.2022;139;3018-3029. [PMC free article: PMC11022970] [PubMed: 34601591]
GurrinLC, OsborneNJ, ConstantineCC, McLarenCE, EnglishDR, GertigDM, DelatyckiMB, SoutheyMC, HopperJL, GilesGG, AndersonGJ, OlynykJK, PowellLW, AllenKJ, et al.The natural history of serum iron indices for HFE C282Y hom*ozygosity associated with hereditary hemochromatosis.Gastroenterology.2008;135:1945–52. [PubMed: 18848943]
HutchinsonC, GeisslerC, PowellJ, BomfordA. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.Gut.2007;56:1291-5. [PMC free article: PMC1954964] [PubMed: 17344278]
IoannouGN, DominitzJA, WeissNS, HeagertyPJ, KowdleyK. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia.Gastroenterology.2004;126:1293-301. [PubMed: 15131790]
KowdleyKV, BrandhagenDJ, GishRG, BassNM, WeinsteinJ, SchilskyML, FontanaRJ, McCashlandT, CotlerSJ, BaconBR, KeeffeEB, GordonF, PolissarN. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.Gastroenterology.2005;129:494–503. [PubMed: 16083706]
KowdleyKV, BrownKE, AhnJ, SundaramV. ACG clinical guideline: hereditary hemochromatosis.Am J Gastroenterol.2019;114:1202-18. [PubMed: 31335359]
KowdleyKV, ModiNB, PeltekianPK, VierlingJM, FerrisC, ValoneFH, GuptaA. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.Lancet Gastroenterol Hepatol.2023;8:1118-28. [PubMed: 37863080]
LebrónJA, BennettMJ, VaughnDE, ChirinoAJ, SnowPM, MintierGA, FederJN, BjorkmanPJ. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.Cell.1998;93:111–23. [PubMed: 9546397]
Le GacG, CongiuR, GourlaouenI, CauM, FérecC, MelisMA. hom*ozygous deletion of HFE is the common cause of hemochromatosis in Sardinia.Haematologica.2010;95:685–7. [PMC free article: PMC2857203] [PubMed: 20007136]
McLarenCE, BartonJC, GordeukVR, WuL, AdamsPC, ReboussinDM, SpeechleyM, ChangH, ActonRT, HarrisEL, RuggieroAM, CastroO, Hemochromatosis and Iron Overload Screen Study Research Investigators. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y hom*ozygotes in the hemochromatosis and iron overload screening study.Am J Hematol.2007;82:898-905 [PubMed: 17597476]
MilmanN, PedersenP, á SteigT, BygKE, GraudalN, FengerK. Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol.2001;80:737–44. [PubMed: 11797115]
MoirandR, AdamsPC, BichelerV, BrissotP, DeugnierY. Clinical features of genetic hemochromatosis in women compared with men.Ann Intern Med.1997;127:105-10. [PubMed: 9229998]
MorrisonED, BrandhagenDJ, PhatakPD, BartonJC, KrawittEL, El-SeragHB, GordonSC, GalanMV, TungBY, IoannouGN, KowdleyKV. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis.Ann Intern Med.2003;138:627–33. [PubMed: 12693884]
NielsenP, FischerR, BuggischP, Janka-SchaubG. Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases.Br J Haematol.2003;123:952-3. [PubMed: 14632789]
OlynykJK, RammGA. Hemochromatosis.N Engl J Med.2022;387:2159-70. [PubMed: 36477033]
OngSY, GurrinLC, DollingL, DixonJ, NicollAJ, WolthuizenM, WoodEM, AndersonGJ, RammGA, AllenKJ, OlynykJK, CrawfordD, RammLE, GowP, DurrantS, PowellLW, DelatyckiMB. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.Lancet Haematol.2017;4:e607–e614. [PubMed: 29195602]
PhatakPD, BonkovskyHL, KowdleyKV. Hereditary hemochromatosis: time for targeted screening.Ann Intern Med.2008;149:270–2. [PubMed: 18711158]
PhatakP, BrissotP, WursterM, AdamsPC, BonkovskyHL, GrossJ, MalfertheinerP, McLarenGD, NiederauC, PipernoA, PowellLW, RussoMW, StoelzelU, StremmelW, GriffelL, LynchN, ZhangY, PietrangeloA. A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.Hepatology.2010;52:1671-779. [PMC free article: PMC3034044] [PubMed: 20814896]
PipernoA, ArosioC, FossatiL, ViganòM, TrombiniP, VerganiA, ManciaG. Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis.Gastroenterology.2000;119:441–5. [PubMed: 10930379]
PipernoA, FargioS, D'AlbaR, RoffiL, FracanzaniAL, VecchiL, FaillaM, FiorelliG. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection.J Hepatol1992;16:364-8. [PubMed: 1487615]
PrabhuA, CargillT, RobertsN, RyanJD. Systematic review of the clinical outcomes of iron reduction in hereditary hemochromatosis.Hepatology2020;72:1469–82. [PubMed: 32500577]
Rombout-SestrienkovaE, NiemanFH, EssersBA, van NoordPA, JanssenMC, van DeursenCT, BosLP, RomboutF, van der BraakR, de LeeuwPW, KoekGH. Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial.Transfusion2012;52:470–7. [PubMed: 21848963]
Rombout-SestrienkovaE, WinkensB, EssersBA, NiemanFH, NoordPA, JanssenMC, van DeursenCTBM, BoonenA, Reuser-KaasengroodEPJM, HeeremansJ, van KraaijM, MascleeA, KoekGH. Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients: results from a randomized crossover trial.Transfusion2016;56:261–70. [PubMed: 26358375]
SchmidtkeJ.Twenty-five years of contemplating genotype-based hereditary hemochromatosis population screening.Genes (Basel). 2022;13:1622. [PMC free article: PMC9498654] [PubMed: 36140790]
ScotetV, MérourMC, MercierAY, ChanuB, Le FaouT, RaguénesO, Le GacG, MuraC, NousbaumJB, FérecC. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients hom*ozygous for the C282Y mutation.Am J Epidemiol.2003;158:129–34. [PubMed: 12851225]
SundicT, HervigT, HannisdalS, AssmusJ, UlvikRJ, OlaussenRW, BerentsonS. Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis.Blood Transfus2014;12:s84–s89. [PMC free article: PMC3934269] [PubMed: 24333062]
WhitingtonPF, KellyS, TaylorSA, NóbregaS, SchreiberRA, SokalEM, HibbardJU. Antenatal treatment with intravenous immunoglobulin to prevent gestational alloimmune liver disease: comparative effectiveness of 14-week versus 18-week initiation.Fetal Diagn Ther.2018;43:218–25. [PubMed: 28787718]
WhitlockEP, GarlitzBA, HarrisEL, BeilTL, SmithPR. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.Ann Intern Med.2006;145:209–23. [PubMed: 16880463]
WoodMJ, PowellLW, RammGA. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis.Blood.2008;111;4456-62. [PubMed: 18316631]
